Shanghai RAAS Blood Products Co Ltd Class A (002252) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai RAAS Blood Products Co Ltd Class A (002252) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-843.75 Million ≈ $-123.47 Million USD) by net assets (CN¥32.46 Billion ≈ $4.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Shanghai RAAS Blood Products Co Ltd Clas to measure how much of total assets are equity-financed.
Shanghai RAAS Blood Products Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Shanghai RAAS Blood Products Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shanghai RAAS Blood Products Co Ltd Clas cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Shanghai RAAS Blood Products Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai RAAS Blood Products Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
INPOST S.A. EO -01
F:669
|
N/A |
|
Parkland Fuel Corporation
TO:PKI
|
0.158x |
|
Compagnie Generale des Etablissements Michelin SCA
LSE:0OFM
|
0.069x |
|
Enstar Group Limited
NASDAQ:ESGR
|
0.023x |
|
Acm Research Inc
NASDAQ:ACMR
|
-0.014x |
|
CHINA TOWER UNSP.ADR/100
F:2Y10
|
N/A |
|
LS Corp
KO:006260
|
0.078x |
|
Corporacion Financiera Alba SA
MC:ALB
|
0.006x |
Annual Cash Flow Conversion Efficiency for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Shanghai RAAS Blood Products Co Ltd Clas market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥32.47 Billion ≈ $4.75 Billion |
CN¥-104.89 Million ≈ $-15.35 Million |
-0.003x | +78.59% |
| 2024-12-31 | CN¥31.94 Billion ≈ $4.67 Billion |
CN¥-482.06 Million ≈ $-70.54 Million |
-0.015x | -119.64% |
| 2023-12-31 | CN¥29.65 Billion ≈ $4.34 Billion |
CN¥2.28 Billion ≈ $333.33 Million |
0.077x | +28.28% |
| 2022-12-31 | CN¥28.81 Billion ≈ $4.22 Billion |
CN¥1.73 Billion ≈ $252.51 Million |
0.060x | +19.89% |
| 2021-12-31 | CN¥25.90 Billion ≈ $3.79 Billion |
CN¥1.29 Billion ≈ $189.35 Million |
0.050x | +7.40% |
| 2020-12-31 | CN¥25.13 Billion ≈ $3.68 Billion |
CN¥1.17 Billion ≈ $171.04 Million |
0.047x | -38.76% |
| 2019-12-31 | CN¥11.49 Billion ≈ $1.68 Billion |
CN¥872.69 Million ≈ $127.70 Million |
0.076x | +215.35% |
| 2018-12-31 | CN¥10.90 Billion ≈ $1.60 Billion |
CN¥262.50 Million ≈ $38.41 Million |
0.024x | +11.83% |
| 2017-12-31 | CN¥12.48 Billion ≈ $1.83 Billion |
CN¥268.76 Million ≈ $39.33 Million |
0.022x | -60.42% |
| 2016-12-31 | CN¥11.73 Billion ≈ $1.72 Billion |
CN¥638.22 Million ≈ $93.39 Million |
0.054x | -23.55% |
| 2015-12-31 | CN¥10.71 Billion ≈ $1.57 Billion |
CN¥762.42 Million ≈ $111.57 Million |
0.071x | +31.73% |
| 2014-12-31 | CN¥8.62 Billion ≈ $1.26 Billion |
CN¥465.96 Million ≈ $68.18 Million |
0.054x | +166.06% |
| 2013-12-31 | CN¥1.10 Billion ≈ $161.22 Million |
CN¥-90.11 Million ≈ $-13.19 Million |
-0.082x | -131.65% |
| 2012-12-31 | CN¥1.02 Billion ≈ $149.18 Million |
CN¥263.46 Million ≈ $38.55 Million |
0.258x | +34.61% |
| 2011-12-31 | CN¥927.27 Million ≈ $135.69 Million |
CN¥178.03 Million ≈ $26.05 Million |
0.192x | -20.29% |
| 2010-12-31 | CN¥831.21 Million ≈ $121.63 Million |
CN¥200.21 Million ≈ $29.30 Million |
0.241x | +58.49% |
| 2009-12-31 | CN¥763.33 Million ≈ $111.70 Million |
CN¥116.01 Million ≈ $16.98 Million |
0.152x | +6.57% |
| 2008-12-31 | CN¥754.76 Million ≈ $110.45 Million |
CN¥107.64 Million ≈ $15.75 Million |
0.143x | -86.20% |
| 2007-12-31 | CN¥170.01 Million ≈ $24.88 Million |
CN¥175.71 Million ≈ $25.71 Million |
1.034x | +202.38% |
| 2006-12-31 | CN¥156.77 Million ≈ $22.94 Million |
CN¥53.58 Million ≈ $7.84 Million |
0.342x | +46.61% |
| 2005-12-31 | CN¥231.70 Million ≈ $33.90 Million |
CN¥54.02 Million ≈ $7.90 Million |
0.233x | -- |
About Shanghai RAAS Blood Products Co Ltd Class A
Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinoge… Read more